Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pankaj Chaturvedi is active.

Publication


Featured researches published by Pankaj Chaturvedi.


The New England Journal of Medicine | 2015

Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer

Abstr Act; Richa Vaish; Neeti Kapre; Mitali Dandekar; Sudeep Gupta; Rohini Hawaldar; Jai Prakash Agarwal; Gouri Pantvaidya; Devendra Chaukar; Anuja Deshmukh; Shubhada Kane; Supreeta Arya; Sarbani Ghosh-Laskar; Pankaj Chaturvedi; Prathamesh Pai; Sudhir Nair; Deepa Nair; Rajendra A. Badwe

BACKGROUND Whether patients with early-stage oral cancers should be treated with elective neck dissection at the time of the primary surgery or with therapeutic neck dissection after nodal relapse has been a matter of debate. METHODS In this prospective, randomized, controlled trial, we evaluated the effect on survival of elective node dissection (ipsilateral neck dissection at the time of the primary surgery) versus therapeutic node dissection (watchful waiting followed by neck dissection for nodal relapse) in patients with lateralized stage T1 or T2 oral squamous-cell carcinomas. Primary and secondary end points were overall survival and disease-free survival, respectively. RESULTS Between 2004 and 2014, a total of 596 patients were enrolled. As prespecified by the data and safety monitoring committee, this report summarizes results for the first 500 patients (245 in the elective-surgery group and 255 in the therapeutic-surgery group), with a median follow-up of 39 months. There were 81 recurrences and 50 deaths in the elective-surgery group and 146 recurrences and 79 deaths in the therapeutic-surgery group. At 3 years, elective node dissection resulted in an improved rate of overall survival (80.0%; 95% confidence interval [CI], 74.1 to 85.8), as compared with therapeutic dissection (67.5%; 95% CI, 61.0 to 73.9), for a hazard ratio for death of 0.64 in the elective-surgery group (95% CI, 0.45 to 0.92; P=0.01 by the log-rank test). At that time, patients in the elective-surgery group also had a higher rate of disease-free survival than those in the therapeutic-surgery group (69.5% vs. 45.9%, P<0.001). Elective node dissection was superior in most subgroups without significant interactions. Rates of adverse events were 6.6% and 3.6% in the elective-surgery group and the therapeutic-surgery group, respectively. CONCLUSIONS Among patients with early-stage oral squamous-cell cancer, elective neck dissection resulted in higher rates of overall and disease-free survival than did therapeutic neck dissection. (Funded by the Tata Memorial Centre; ClinicalTrials.gov number, NCT00193765.).


Lancet Oncology | 2014

Challenges to effective cancer control in China, India, and Russia

Paul E. Goss; Kathrin Strasser-Weippl; Brittany L. Lee-Bychkovsky; Lei Fan; Junjie Li; Yanin Chavarri-Guerra; Pedro E.R. Liedke; C.S. Pramesh; Tanja Badovinac-Crnjevic; Yuri Sheikine; Zhu Chen; You-Lin Qiao; Zhiming Shao; Yi-Long Wu; Daiming Fan; Louis W.C. Chow; Jun Wang; Qiong Zhang; Shiying Yu; Gordon Shen; Jie He; Arnie Purushotham; Richard Sullivan; Rajendra A. Badwe; Shripad Banavali; Reena Nair; Lalit Kumar; Purvish M. Parikh; Somasundarum Subramanian; Pankaj Chaturvedi

Cancer is one of the major non-communicable diseases posing a threat to world health. Unfortunately, improvements in socioeconomic conditions are usually associated with increased cancer incidence. In this Commission, we focus on China, India, and Russia, which share rapidly rising cancer incidence and have cancer mortality rates that are nearly twice as high as in the UK or the USA, vast geographies, growing economies, ageing populations, increasingly westernised lifestyles, relatively disenfranchised subpopulations, serious contamination of the environment, and uncontrolled cancer-causing communicable infections. We describe the overall state of health and cancer control in each country and additional specific issues for consideration: for China, access to care, contamination of the environment, and cancer fatalism and traditional medicine; for India, affordability of care, provision of adequate health personnel, and sociocultural barriers to cancer control; and for Russia, monitoring of the burden of cancer, societal attitudes towards cancer prevention, effects of inequitable treatment and access to medicine, and a need for improved international engagement.


Radiotherapy and Oncology | 2012

Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial

Tejpal Gupta; Jai Prakash Agarwal; Sandeep Jain; Reena Phurailatpam; Sadhana Kannan; Sarbani Ghosh-Laskar; Vedang Murthy; Ashwini Budrukkar; Ketayun A. Dinshaw; Kumar Prabhash; Pankaj Chaturvedi; Anil D’Cruz

PURPOSE To compare three-dimensional conformal radiotherapy (3D-CRT) with intensity modulated radiation therapy (IMRT) in curative-intent irradiation of head-neck squamous cell carcinoma (HNSCC). METHODS Previously untreated patients with biopsy-proven squamous carcinoma of oropharynx, larynx, or hypopharynx (T1-3, N0-2b) were randomly assigned using computer-generated permuted-block design to either 3D-CRT or IMRT, with incidence of physician-rated Radiation Therapy Oncology Group (RTOG) grade 2 or worse acute salivary gland toxicity as primary end-point. RESULTS Between 2005 and 2008, 60 patients randomly allocated to either 3D-CRT (n=28 patients) or IMRT (n=32) were included and analyzed on an intention-to-treat basis. The proportion [95% confidence intervals (CI)] of patients with RTOG grade 2 or worse acute salivary gland toxicity was significantly lesser in the IMRT arm [19 of 32 patients (59%, 95%CI: 42-75%)] as compared to 3D-CRT [25 of 28 patients (89%, 95%CI: 72-97%; p=0.009)]. Late xerostomia and subcutaneous fibrosis were also significantly lesser with IMRT. There was significant recovery of salivary function over time in patients treated with IMRT (p-value for trend=0.0036). At 3-years, there were no significant differences in loco-regional control or survival between the two arms. CONCLUSION IMRT significantly reduces the incidence and severity of xerostomia compared to 3D-CRT in curative-intent irradiation of HNSCC.


Nature Communications | 2013

Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups

Arindam Maitra; Nidhan K. Biswas; Kishore Amin; Pradnya Kowtal; Shantanu Kumar; Subrata Das; Rajiv Sarin; Partha P. Majumder; I. Bagchi; Bairagya Bb; Analabha Basu; M.K. Bhan; Pankaj Chaturvedi; Debrup Das; A. D’Cruz; R. Dhar; Debnarayan Dutta; Debdutta Ganguli; P. Gera; Tejpal Gupta; S. Mahapatra; M.H.K. Mujawar; Souvik Mukherjee; Sajini B. Nair; Santosh Nikam; M. Nobre; Asawari Patil; S. Patra; M. Rama-Gowtham; T.S. Rao

Gingivo-buccal oral squamous cell carcinoma (OSCC-GB), an anatomical and clinical subtype of head and neck squamous cell carcinoma (HNSCC), is prevalent in regions where tobacco-chewing is common. Exome sequencing (n=50) and recurrence testing (n=60) reveals that some significantly and frequently altered genes are specific to OSCC-GB (USP9X, MLL4, ARID2, UNC13C and TRPM3), while some others are shared with HNSCC (for example, TP53, FAT1, CASP8, HRAS and NOTCH1). We also find new genes with recurrent amplifications (for example, DROSHA, YAP1) or homozygous deletions (for example, DDX3X) in OSCC-GB. We find a high proportion of C>G transversions among tobacco users with high numbers of mutations. Many pathways that are enriched for genomic alterations are specific to OSCC-GB. Our work reveals molecular subtypes with distinctive mutational profiles such as patients predominantly harbouring mutations in CASP8 with or without mutations in FAT1. Mean duration of disease-free survival is significantly elevated in some molecular subgroups. These findings open new avenues for biological characterization and exploration of therapies.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2009

Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: Need for a randomized controlled trial

Anil D'Cruz; Ravichand C. Siddachari; Rohan R. Walvekar; Gouri Pantvaidya; Devendra Chaukar; Mandar S. Deshpande; Prathamesh Pai; Pankaj Chaturvedi

The aim of this study is to determine the need for a randomized controlled trial in order to define the role of an elective neck dissection (END) in the treatment of early tongue cancers.


Oral Oncology | 2009

Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases

Rohan R. Walvekar; Devendra Chaukar; Mandar S. Deshpande; Prathamesh Pai; Pankaj Chaturvedi; Anagha Kakade; S. Kane; Anil D’Cruz

This paper studies the clinical and pathological predictors of local recurrence and disease-free survival (DFS) in patients with oral verrucous carcinoma (OVC) treated surgically, through a retrospective chart review. Three hundred and two patients with OVC were identified from January 1990 to December 2000, of which, 101 surgically treated patients who fulfilled our inclusion criteria were analyzed. A univariate analysis (UVA) of important prognostic factors, patterns of recurrence, and DFS is reported. Seventy-nine patients were male (M:F ratio, 3.6:1) and the mean age at presentation was 53.9 years (range, 23-90 years). The median follow up was 4.61 years (range, 0.51-14.3 years). The incidence of tobacco chewing, smoking, and alcohol intake was 77%, 42%, and 10%, respectively. Thirty-four patients (33.7%) had either leukoplakia or submucous fibrosis (SMF) on oral cavity examination. Early-stage tumors accounted for 39.7%; while 60.4% were late-stage tumors. On UVA, tumor location, presence of a premalignant lesion, smoking, and positive margins were statistically significant. Sixty-eight percent (19/28) recurred locally. The salvage rate for recurrent tumors was 66.7% (16/28) with a median post-recurrence survival of 16 months (range, 10-83 months). The five year DFS with surgical therapy was 77.6%. OVC has an excellent prognosis with surgical treatment. The significance of positive margins emphasizes the need for adequate surgical resection. Additionally, the presence of either leukoplakia or SMF and tumor location in the upper alveolar-palatal complex is associated with worse outcomes. Neck dissection, if considered, may be limited to a supra-omohyoid neck dissection (SOHND).


British Journal of Cancer | 2013

Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research

Snehal G. Patel; Moran Amit; Tzu Chen Yen; Chun-Ta Liao; Pankaj Chaturvedi; Jai Prakash Agarwal; Luiz P. Kowalski; Ardalan Ebrahimi; Jonathan R. Clark; Claudio Roberto Cernea; S. J. Brandao; Matthias Kreppel; Joachim E. Zöller; Dan M. Fliss; Eran Fridman; Gideon Bachar; Thomas Shpitzer; V. A. Bolzoni; P. R. Patel; S. Jonnalagadda; K. T. Robbins; Jatin P. Shah; Ziv Gil

Background:Lymph node density (LND) has previously been reported to reliably predict recurrence risk and survival in oral cavity squamous cell carcinoma (OSCC). This multicenter international study was designed to validate the concept of LND in OSCC.Methods:The study included 4254 patients diagnosed as having OSCC. The median follow-up was 41 months. Five-year overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS), locoregional control and distant metastasis rates were calculated using the Kaplan–Meier method. Lymph node density (number of positive lymph nodes/total number of excised lymph nodes) was subjected to multivariate analysis.Results:The OS was 49% for patients with LND⩽0.07 compared with 35% for patients with LND>0.07 (P<0.001). Similarly, the DSS was 60% for patients with LND⩽0.07 compared with 41% for those with LND>0.07 (P<0.001). Lymph node density reliably stratified patients according to their risk of failure within the individual N subgroups (P=0.03). A modified TNM staging system based on LND ratio was consistently superior to the traditional system in estimating survival measures.Conclusion:This multi-institutional study validates the reliability and applicability of LND as a predictor of outcomes in OSCC. Lymph node density can potentially assist in identifying patients with poor outcomes and therefore for whom more aggressive adjuvant treatment is needed.


Journal of Biomedical Optics | 2012

In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa.

S. P. Singh; Atul Deshmukh; Pankaj Chaturvedi; C. Murali Krishna

Abstract. Cancers of oral cavities are one of the most common malignancies in India and other south-Asian countries. Tobacco habits are the main etiological factors for oral cancer. Identification of premalignant lesions is required for improving survival rates related to oral cancer. Optical spectroscopy methods are projected as alternative/adjunct for cancer diagnosis. Earlier studies have demonstrated the feasibility of classifying normal, premalignant, and malignant oral ex-vivo tissues. We intend to evaluate potentials of Raman spectroscopy in detecting premalignant conditions. Spectra were recorded from premalignant patches, contralateral normal (opposite to tumor site), and cancerous sites of subjects with oral cancers and also from age-matched healthy subjects with and without tobacco habits. A total of 861 spectra from 104 subjects were recorded using a fiber-optic probe-coupled HE-785 Raman spectrometer. Spectral differences in the 1200- to 1800-cm−1 region were subjected to unsupervised principal component analysis and supervised linear discriminant analysis followed by validation with leave-one-out and an independent test data set. Results suggest that premalignant conditions can be objectively discriminated with both normal and cancerous sites as well as from healthy controls with and without tobacco habits. Findings of the study further support efficacy of Raman spectroscopic approaches in oral-cancer applications.


Journal of Cancer Research and Therapeutics | 2005

A prospective study of pharyngocutaneous fistulas following total laryngectomy

Sajid S. Qureshi; Pankaj Chaturvedi; P. Pai; Devendra Chaukar; Mandar S. Deshpande; Kumar Alok Pathak

Pharyngocutaneous (PC) fistula is a common complication following laryngectomy. It leads to increased morbidity, delay in adjuvant treatment, prolonged hospitalization and an increase in treatment costs. Although a number of factors that result in PC fistula have been described, there is still no agreement on the most significant factors. We undertook a prospective study to critically analyze PC fistula and its association with various tumors, patient and treatment related factors. This was a prospective study that included 143 patients who underwent laryngeal surgery for squamous cell carcinoma of the larynx and pyriform sinus. Use of pectoralis major myocutaneous flap to reconstruct the neopharynx, primary disease in pyriform and extensive soft tissue infiltration were significantly associated with PC fistula. Prior treatment (radiotherapy and chemotherapy), type of closure (T closure, Y closure and vertical closure), Layers of closure (full thickness interrupted, submucosal interrupted, submucosal continuous) type of suture material (silk, vicryl ), age, sex, stage, preoperative tracheostomy, cut margin status, pre/postoperative hemoglobin and experience of surgeons did not relate significantly.


Cancer | 2013

Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study

Moran Amit; Tzu Chen Yen; Chun Ta Liao; Pankaj Chaturvedi; Jai Prakash Agarwal; Luiz Paulo Kowalski; Ardalan Ebrahimi; Jonathan R. Clark; Matthias Kreppel; Joachim E. Zöller; Eran Fridman; Villaret A. Bolzoni; Jatin P. Shah; Yoav Binenbaum; Snehal G. Patel; Ziv Gil

An association between the survival of patients with oral cavity squamous cell carcinoma (OCSCC) and advancements in diagnosis and therapy has not been established.

Collaboration


Dive into the Pankaj Chaturvedi's collaboration.

Top Co-Authors

Avatar

Anil D'Cruz

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Deepa Nair

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sudhir Nair

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Pai

Tata Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge